Terrible result.
Revenue only single digit growth (do I hear growth company?), EPS dropped by nearly 25 % from a low base. 7.8 million NPAT, negative earnings growth and a nearly $500 million market cap - something does not fit?
Add to that that other health companies creamed it in the past year - what the hell are AFT doing? This should have been one of its great years ...
Bookmarks